0 avis
Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial
Archive ouverte
Edité par CCSD ; American Heart Association -
International audience. Strokes were significantly reduced by the combination of rivaroxaban plus aspirin compared with aspirin in the COMPASS Trial. We present detailed analyses of stroke by type, predictors, and antithrombotic effects in key subgroups. . URL: https://www.clinicaltrials.gov Unique Identifier: NCT01776424.